drugset / Trial / NCT00002635
Aminocamptothecin in Treating Patients With T-cell Lymphoma
NaSingle-groupTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of aminocamptothecin in treating patients with advanced cutaneous T-cell lymphoma.
Timeline
- Start
- 1995-05
- Primary completion
- 2000-04
- Completion
- 2000-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 9-aminocamptothecin | Small molecule | — | — |
| Background | filgrastim | Protein / enzyme biologic | — | — |